The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate. [electronic resource]
Producer: 20091207Description: 2063-74 p. digitalISSN:- 1476-5551
- Animals
- Antigens, CD34 -- metabolism
- B-Lymphocytes -- cytology
- Cell Differentiation -- drug effects
- Cell Line
- Cell Lineage -- drug effects
- DNA-Binding Proteins -- genetics
- Fetal Blood -- cytology
- Hematopoietic Stem Cells -- cytology
- Humans
- Lipopeptides -- pharmacology
- Lymphopoiesis -- drug effects
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Myeloid Cells -- cytology
- Stromal Cells -- cytology
- Toll-Like Receptor 1 -- agonists
- Toll-Like Receptor 2 -- agonists
- Transcription, Genetic -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.